Clinical trial

Study of Concurrent Chemo-radiotherapy Combined With Recombinant Human Endostatin for Local Advanced Non-small Cell Lung Cancer (NSCLC)

NCT01211002

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE4

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2010-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

radiotherapy combined with EPRADIATION

radiotherapy / EP combined with recombinant human endostatinDRUG

Sponsors & collaborators

Simcere Pharmaceutical Co., Ltdlead sponsor

Daping Hospital and the Research Institute of Surgery of the Third Military Medical Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01211002 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.